Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Belated Introduction to Dr. Charu Aggarwal
Dr West
Author
Howard (Jack) West, MD

Many of you already participating on the lung cancer section of the GRACE site have seen the first few responses by Dr. Aggarwal, though they have preceded my proper introduction of her.  Apologies -- we had talked a few months ago about having her start sometime around now, though I hadn't anticipated her laudable enthusiasm and courage to jump right in.  So let me now provide a little background.  

Dr. Charu Aggarwal is an Assistant Professor in the Hematology/Oncology Division at the University of Pennsylvania, where she has a particular focus on lung cancer.  She started her medical training at the Lady Hardinge Medical College in New Delhi, then came to the US and did a Master’s in Public Health at the University of Alabama, Birmingham.  She then did her internship and residency training in internal medicine at the State University of New York, Buffalo before moving to Philadelphia to do her medical oncology fellowship training at the Fox Chase Cancer Center.   Last year she moved to the University of Pennsylvania to join their faculty.  

 

Our friend Dr. Weiss here has known Dr. Aggarwal from his time in Philadelphia, as he had trained at the University of Pennsylvania and knew Dr. Aggarwal from the cancer scene in Philadelphia (I guess if you consider there to be such a thing).  He had recommended here, and I've had the chance to spend some time talking with and trying to recruit her to work with us.  Her background includes an impressive collection of awards for academic achievements, her research efforts, and bedside manner -- I think this is a great combination that I hope will lead to her becoming a recurring, always welcomed addition to the GRACE faculty.

 

Next Previous link

Previous PostNext Post

Related Content

Online Community

A Brief Tornado.  I love the analogy Dr. Antonoff gave us to describe her presentation.  I felt it earlier too and am looking forward to going back for deeper dive.

Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".

While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".  

I hope any...

My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Recent Comments

JOIN THE CONVERSATION
My understanding of ADCs is…
By JanineT GRACE … on
Right patient, right time,…
By JanineT GRACE … on
A Brief Tornado.  I love the…
By JanineT GRACE … on
Biomarkers
By JanineT GRACE … on